Adjuvant Trastuzumab Therapy: Can We Balance Efficacy and Safety?

We describe a potential approach undertaken by our group, and others, and call for a randomized trial.
PMID: 31315962 [PubMed - as supplied by publisher]

Source: The Oncologist - July 16, 2019 Category: Cancer & Oncology Authors: Barron CC, Tyagi NK, Alhussein MM, Mukherjee SD, Ellis PM, Dhesy-Thind S, Leong DP Tags: Oncologist Source Type: research